Prescription Drug Affordability & Innovation: Policy Options & Stakeholder Views

Balancing prescription medicine access, affordability, and innovation has been a focus of recent policy conversations. This Alliance for Health Policy briefing discussed current issues in prescription drug affordability and innovation, focusing on potential policy and private-sector approaches to this complex issue.

  • Hon. Henry Waxman, Waxman Strategies
  • Joel White, Council for Affordable Health Coverage
  • Steve Miller, Express Scripts
  • David Mitchell, Patients for Affordable Drugs
  • Robert Zirkelbach, PhRMA
  • Larry Kocot of KPMG moderated the discussion.

Follow this event on Twitter: